A chemokine-like viral protein enhances alpha interferon production by plasmacytoid dendritic cells but delays CD8+ T cell activation and impairs viral clearance

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 7911-7920

  Wikstrom, Matthew E ^a,b   Fleming, Peter ^a,b   Comerford, Iain ^a,c   McColl, Shaun R ^c   Andoniou, Christopher E ^a,b   Degli Esposti, Mariapia A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MCK 2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOMEGALOVIRUS INFECTION; IMMUNE EVASION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL CLEARANCE; VIRUS REPLICATION; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHEMOKINES, CC; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERON-ALPHA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; SPLEEN; STATISTICS, NONPARAMETRIC; VIRAL PROTEINS;

EID: 84880307279     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00187-13     Document Type: Article

References (54)

1. Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ. 2011. Viral evasion of T cell immunity: ancient mechanisms offering new applications. Curr. Opin. Immunol. 23:96-103.
2. Lanier LL. 2008. Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 8:259-268.
3. Bowie AG, Unterholzner L. 2008. Viral evasion and subversion of pattern- recognition receptor signalling. Nat. Rev. Immunol. 8:911-922.
4. Miller-Kittrell M, Sparer TE. 2009. Feeling manipulated: cytomegalovirus immune manipulation. Virol. J. 6:4. doi:10.1186/1743-422X-6-4.
5. Beutler B, Georgel P, Rutschmann S, Jiang Z, Croker B, Crozat K. 2005. Genetic analysis of innate resistance to mouse cytomegalovirus (MCMV). Brief. Funct. Genomic. Proteomic. 4:203-213.
6. Fleming P, Davis-Poynter N, Degli-Esposti M, Densley E, Papadimitriou J, Shellam G, Farrell H. 1999. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol. 73:6800-6809.
7. Saederup N, Aguirre SA, Sparer TE, Bouley DM, Mocarski ES. 2001. Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) isa determinant of dissemination that increases inflammation at initial sites of infection. J. Virol. 75:9966-9976.
8. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES. 1999. Cytomegalovirus-encoded beta chemokine promotes monocyteassociated viremia in the host. Proc. Natl. Acad. Sci. U. S. A. 96:10881-10886.
9. MacDonald MR, Burney MW, Resnick SB, Virgin HI. 1999. Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure. J. Virol. 73:3682-3691.
10. Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES. 2006. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30-38.
11. Scalzo AA, Brown MG, Chu DT, Heusel JW, Yokoyama WM, Forbes CA. 1999. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49:238-241.
12. Allan JE, Shellam GR. 1984. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch. Virol. 81:139-150.
13. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM. 2009. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J. Gen. Virol. 90:33-43.
14. Keil GM, Fibi MR, Koszinowski UH. 1985. Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. J. Virol. 54:422-428.
15. Barber DL, Wherry EJ, Ahmed R. 2003. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171:27-31.
16. Kohler RE, Caon AC, Willenborg DO, Clark-Lewis I, McColl SR. 2003. A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J. Immunol. 170:6298-6306.
17. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA. 2009. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cellmediated antiviral activity. Immunol. Cell Biol. 87:559-566.
18. Reddehase MJ, Rothbard JB, Koszinowski UH. 1989. A pentapeptide as minimal antigenic determinant forMHCclass I-restricted T lymphocytes. Nature 337:651-653.
19. + T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon. J. Virol. 82:4931-4937.
20. Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, van der Most RG, Scalzo AA, Smyth MJ, Degli-Esposti MA. 2010. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207:1333-1343.
21. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, Biron CA. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197:885-898.
22. Heise MT, Virgin HW, IV. 1995. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J. Virol. 69:904-909.
23. Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M. 2007. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3:e123. doi:10.1371/journal.ppat.0030123.
24. Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-937.
25. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:951-956.
26. Scalzo AA, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469-1483.
27. + T cell immunity by recruiting inflammatory monocytes. Immunity 37:122-133.
28. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW, IV. 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J. Exp. Med. 188:577-588.
29. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F, Trinchieri G, Biron CA. 2002. Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
30. Delale T, Paquin A, Asselin-Paturel C, Dalod M, Brizard G, Bates EE, Kastner P, Chan S, Akira S, Vicari A, Biron CA, Trinchieri G, Briere F. 2005. MyD88-dependent and-independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo. J. Immunol. 175:6723-6732.
31. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, Orihuela MM, Akira S, Yokoyama WM, Colonna M. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119.
32. Orange JS, Biron CA. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
33. Schneider K, Loewendorf A, De Trez C, Fulton J, Rhode A, Shumway H, Ha S, Patterson G, Pfeffer K, Nedospasov SA, Ware CF, Benedict CA. 2008. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3:67-76.
34. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. 2010. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 33:955-966.
35. Zucchini N, Bessou G, Robbins SH, Chasson L, Raper A, Crocker PR, Dalod M. 2008. Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organspecific manner during viral infection. Int. Immunol. 20:45-56.
36. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6:1011-1019.
37. Banks TA, Rickert S, Benedict CA, Ma L, Ko M, Meier J, Ha W, Schneider K, Granger SW, Turovskaya O, Elewaut D, Otero D, French AR, Henry SC, Hamilton JD, Scheu S, Pfeffer K, Ware CF. 2005. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection. J. Immunol. 174:7217-7225.
38. Benedict CA, Banks TA, Senderowicz L, Ko M, Britt WJ, Angulo A, Ghazal P, Ware CF. 2001. Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15:617-626.
39. Kranzer K, Bauer M, Lipford GB, Heeg K, Wagner H, Lang R. 2000. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon- gamma production and up-regulation of CD69 via induction of antigen- presenting cell-derived interferon type I and interleukin-12. Immunology 99:170-178.
40. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287.
41. Bosio E, Beilharz MW, Watson MW, Lawson CM. 1999. Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. J. Interferon Cytokine Res. 19:869-876.
42. Sainz B, Jr, LaMarca HL, Garry RF, Morris CA. 2005. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol. J. 2:14. doi:10.1186/1743-422X-2-14.
43. Benedict CA, De Trez C, Schneider K, Ha S, Patterson G, Ware CF. 2006. Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog. 2:e16. doi:10.1371/journal.ppat.0020016.
44. Mueller SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, Locksley RM, Ahmed R, Matloubian M. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317:670-674.
45. Kaptein SJ, van Cleef KW, Gruijthuijsen YK, Beuken EV, van Buggenhout L, Beisser PS, Stassen FR, Bruggeman CA, Vink C. 2004. The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands. Virus Genes 29:43-61.
46. Nozawa N, Yamamoto Y, Fukui Y, Katano H, Tsutsui Y, Sato Y, Yamada S, Inami Y, Nakamura K, Yokoi M, Kurane I, Inoue N. 2008. Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture. Virology 379:45-54.
47. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033.
48. Ryckman BJ, Chase MC, Johnson DC. 2008. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell typespecific receptors. Proc. Natl. Acad. Sci. U. S. A. 105:14118-14123.
49. Ryckman BJ, Rainish BL, Chase MC, Borton JA, Nelson JA, Jarvis MA, Johnson DC. 2008. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82:60-70.
50. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
51. Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski UH, Adler B. 2011. Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr shows reduced growth in salivary glands due to a fixed mutation of MCK-2. J. Virol. 85:10346-10353.
52. Smith LM, Shellam GR, Redwood AJ. 2006. Genes of murine cytomegalovirus exist as a number of distinct genotypes. Virology 352:450-465.
53. Alcami A, Lira SA. 2010. Modulation of chemokine activity by viruses. Curr. Opin. Immunol. 22:482-487.
54. Seet BT, McFadden G. 2002. Viral chemokine-binding proteins. J. Leukoc. Biol. 72:24-34.